Need help finding what you are looking for?
Contact Us
PUBLISHER: 360iResearch | PRODUCT CODE: 1434514
PUBLISHER: 360iResearch | PRODUCT CODE: 1434514
Allergy Drugs Market by Type (Drug Allergy, Food Allergy, Inhaled Allergy), Treatment (Anti-allergy Drugs, Immunotherapy), Distribution Channels - Global Forecast 2024-2030
PUBLISHED:
PAGES: 194 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
[194 Pages Report] The Allergy Drugs Market size was estimated at USD 29.71 billion in 2023 and expected to reach USD 32.21 billion in 2024, at a CAGR 8.48% to reach USD 52.54 billion by 2030.
Global Allergy Drugs Market
| KEY MARKET STATISTICS | |
|---|---|
| Base Year [2023] | USD 29.71 billion |
| Estimated Year [2024] | USD 32.21 billion |
| Forecast Year [2030] | USD 52.54 billion |
| CAGR (%) | 8.48% |
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Allergy Drugs Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Allergy Drugs Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Allergy Drugs Market, highlighting leading vendors and their innovative profiles. These include Allergy Therapeutics PLC, Astra Biotech GmbH, AstraZeneca PLC, Bayer AG, GlaxoSmithKline PLC, HAL Allergy B.V., Hikma Pharmaceuticals PLC, Johnson & Johnson Services, Inc., LETI Pharma, S.L.U., Lupin Limited, Mylan N.V. by Viatris Inc., Novartis AG, Sanofi SA, Teva Pharmaceutical Industries Ltd., and XOLAIR by F. Hoffmann-La Roche AG.
Market Segmentation & Coverage
This research report categorizes the Allergy Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:
- Type
- Drug Allergy
- Food Allergy
- Inhaled Allergy
- Treatment
- Anti-allergy Drugs
- Antihistamines
- Corticosteroids
- Leukotriene Inhibitors
- Immunotherapy
- Subcutaneous Immunotherapy (SCIT) Sublingual Immunotherapy (SLIT)
- Anti-allergy Drugs
- Distribution Channels
- Hospital Pharmacies
- Online Pharmacies
- Retail Pharmacies & Drug Stores
- Region
- Americas
- Argentina
- Brazil
- Canada
- Mexico
- United States
- California
- Florida
- Illinois
- New York
- Ohio
- Pennsylvania
- Texas
- Asia-Pacific
- Australia
- China
- India
- Indonesia
- Japan
- Malaysia
- Philippines
- Singapore
- South Korea
- Taiwan
- Thailand
- Vietnam
- Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom
- Americas
The report offers valuable insights on the following aspects:
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
1. What is the market size and forecast of the Allergy Drugs Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Allergy Drugs Market?
3. What are the technology trends and regulatory frameworks in the Allergy Drugs Market?
4. What is the market share of the leading vendors in the Allergy Drugs Market?
5. Which modes and strategic moves are suitable for entering the Allergy Drugs Market?
Product Code: MRR-434CCDA051E6
Table of Contents
1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
- 4.1. Introduction
- 4.2. Allergy Drugs Market, by Region
5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Growing prevalence of allergy globally
- 5.1.1.2. Increasing development of allergy-specific drugs
- 5.1.1.3. Rise in prevalence towards over the counter drugs
- 5.1.2. Restraints
- 5.1.2.1. Concerns over patent expiration and extensive competition from generic drugs
- 5.1.3. Opportunities
- 5.1.3.1. Introduction of immunotherapy and development of increasing ways of administration
- 5.1.3.2. Rising consumer awareness on food allergies
- 5.1.4. Challenges
- 5.1.4.1. Availability of alternative drugs for allergy
- 5.1.1. Drivers
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of High Inflation
- 5.5. Porter's Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
- 5.6. Value Chain & Critical Path Analysis
- 5.7. Regulatory Framework
6. Allergy Drugs Market, by Type
- 6.1. Introduction
- 6.2. Drug Allergy
- 6.3. Food Allergy
- 6.4. Inhaled Allergy
7. Allergy Drugs Market, by Treatment
- 7.1. Introduction
- 7.2. Anti-allergy Drugs
- 7.3.1. Antihistamines
- 7.3.2. Corticosteroids
- 7.3.3. Leukotriene Inhibitors
- 7.3. Immunotherapy
- 7.4.1. Subcutaneous Immunotherapy (SCIT) Sublingual Immunotherapy (SLIT)
8. Allergy Drugs Market, by Distribution Channels
- 8.1. Introduction
- 8.2. Hospital Pharmacies
- 8.3. Online Pharmacies
- 8.4. Retail Pharmacies & Drug Stores
9. Americas Allergy Drugs Market
- 9.1. Introduction
- 9.2. Argentina
- 9.3. Brazil
- 9.4. Canada
- 9.5. Mexico
- 9.6. United States
10. Asia-Pacific Allergy Drugs Market
- 10.1. Introduction
- 10.2. Australia
- 10.3. China
- 10.4. India
- 10.5. Indonesia
- 10.6. Japan
- 10.7. Malaysia
- 10.8. Philippines
- 10.9. Singapore
- 10.10. South Korea
- 10.11. Taiwan
- 10.12. Thailand
- 10.13. Vietnam
11. Europe, Middle East & Africa Allergy Drugs Market
- 11.1. Introduction
- 11.2. Denmark
- 11.3. Egypt
- 11.4. Finland
- 11.5. France
- 11.6. Germany
- 11.7. Israel
- 11.8. Italy
- 11.9. Netherlands
- 11.10. Nigeria
- 11.11. Norway
- 11.12. Poland
- 11.13. Qatar
- 11.14. Russia
- 11.15. Saudi Arabia
- 11.16. South Africa
- 11.17. Spain
- 11.18. Sweden
- 11.19. Switzerland
- 11.20. Turkey
- 11.21. United Arab Emirates
- 11.22. United Kingdom
12. Competitive Landscape
- 12.1. FPNV Positioning Matrix
- 12.2. Market Share Analysis, By Key Player
- 12.3. Competitive Scenario Analysis, By Key Player
13. Competitive Portfolio
- 13.1. Key Company Profiles
- 13.1.1. Allergy Therapeutics PLC
- 13.1.2. Astra Biotech GmbH
- 13.1.3. AstraZeneca PLC
- 13.1.4. Bayer AG
- 13.1.5. GlaxoSmithKline PLC
- 13.1.6. HAL Allergy B.V.
- 13.1.7. Hikma Pharmaceuticals PLC
- 13.1.8. Johnson & Johnson Services, Inc.
- 13.1.9. LETI Pharma, S.L.U.
- 13.1.10. Lupin Limited
- 13.1.11. Mylan N.V. by Viatris Inc.
- 13.1.12. Novartis AG
- 13.1.13. Sanofi SA
- 13.1.14. Teva Pharmaceutical Industries Ltd.
- 13.1.15. XOLAIR by F. Hoffmann-La Roche AG
- 13.2. Key Product Portfolio
14. Appendix
- 14.1. Discussion Guide
- 14.2. License & Pricing
Product Code: MRR-434CCDA051E6
LIST OF FIGURES
- FIGURE 1. ALLERGY DRUGS MARKET RESEARCH PROCESS
- FIGURE 2. ALLERGY DRUGS MARKET SIZE, 2023 VS 2030
- FIGURE 3. ALLERGY DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. ALLERGY DRUGS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
- FIGURE 5. ALLERGY DRUGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. ALLERGY DRUGS MARKET DYNAMICS
- FIGURE 7. ALLERGY DRUGS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
- FIGURE 8. ALLERGY DRUGS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 9. ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2023 VS 2030 (%)
- FIGURE 10. ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 11. ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2023 VS 2030 (%)
- FIGURE 12. ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 13. AMERICAS ALLERGY DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 14. AMERICAS ALLERGY DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 15. UNITED STATES ALLERGY DRUGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 16. UNITED STATES ALLERGY DRUGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 17. ASIA-PACIFIC ALLERGY DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 18. ASIA-PACIFIC ALLERGY DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ALLERGY DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ALLERGY DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 21. ALLERGY DRUGS MARKET, FPNV POSITIONING MATRIX, 2023
- FIGURE 22. ALLERGY DRUGS MARKET SHARE, BY KEY PLAYER, 2023
LIST OF TABLES
- TABLE 1. ALLERGY DRUGS MARKET SEGMENTATION & COVERAGE
- TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
- TABLE 3. ALLERGY DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
- TABLE 4. GLOBAL ALLERGY DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
- TABLE 5. ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 6. ALLERGY DRUGS MARKET SIZE, BY DRUG ALLERGY, BY REGION, 2018-2030 (USD MILLION)
- TABLE 7. ALLERGY DRUGS MARKET SIZE, BY FOOD ALLERGY, BY REGION, 2018-2030 (USD MILLION)
- TABLE 8. ALLERGY DRUGS MARKET SIZE, BY INHALED ALLERGY, BY REGION, 2018-2030 (USD MILLION)
- TABLE 9. ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 10. ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, BY REGION, 2018-2030 (USD MILLION)
- TABLE 11. ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
- TABLE 12. ALLERGY DRUGS MARKET SIZE, BY ANTIHISTAMINES, BY REGION, 2018-2030 (USD MILLION)
- TABLE 13. ALLERGY DRUGS MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2018-2030 (USD MILLION)
- TABLE 14. ALLERGY DRUGS MARKET SIZE, BY LEUKOTRIENE INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
- TABLE 15. ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
- TABLE 16. ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
- TABLE 17. ALLERGY DRUGS MARKET SIZE, BY SUBCUTANEOUS IMMUNOTHERAPY (SCIT) SUBLINGUAL IMMUNOTHERAPY (SLIT), BY REGION, 2018-2030 (USD MILLION)
- TABLE 18. ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
- TABLE 19. ALLERGY DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
- TABLE 20. ALLERGY DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
- TABLE 21. ALLERGY DRUGS MARKET SIZE, BY RETAIL PHARMACIES & DRUG STORES, BY REGION, 2018-2030 (USD MILLION)
- TABLE 22. AMERICAS ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 23. AMERICAS ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 24. AMERICAS ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
- TABLE 25. AMERICAS ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
- TABLE 26. AMERICAS ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
- TABLE 27. AMERICAS ALLERGY DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 28. ARGENTINA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 29. ARGENTINA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 30. ARGENTINA ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
- TABLE 31. ARGENTINA ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
- TABLE 32. ARGENTINA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
- TABLE 33. BRAZIL ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 34. BRAZIL ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 35. BRAZIL ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
- TABLE 36. BRAZIL ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
- TABLE 37. BRAZIL ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
- TABLE 38. CANADA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 39. CANADA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 40. CANADA ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
- TABLE 41. CANADA ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
- TABLE 42. CANADA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
- TABLE 43. MEXICO ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 44. MEXICO ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 45. MEXICO ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
- TABLE 46. MEXICO ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
- TABLE 47. MEXICO ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
- TABLE 48. UNITED STATES ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 49. UNITED STATES ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 50. UNITED STATES ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
- TABLE 51. UNITED STATES ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
- TABLE 52. UNITED STATES ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
- TABLE 53. UNITED STATES ALLERGY DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
- TABLE 54. ASIA-PACIFIC ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 55. ASIA-PACIFIC ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 56. ASIA-PACIFIC ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
- TABLE 57. ASIA-PACIFIC ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
- TABLE 58. ASIA-PACIFIC ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
- TABLE 59. ASIA-PACIFIC ALLERGY DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 60. AUSTRALIA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 61. AUSTRALIA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 62. AUSTRALIA ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
- TABLE 63. AUSTRALIA ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
- TABLE 64. AUSTRALIA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
- TABLE 65. CHINA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 66. CHINA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 67. CHINA ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
- TABLE 68. CHINA ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
- TABLE 69. CHINA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
- TABLE 70. INDIA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 71. INDIA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 72. INDIA ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
- TABLE 73. INDIA ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
- TABLE 74. INDIA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
- TABLE 75. INDONESIA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 76. INDONESIA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 77. INDONESIA ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
- TABLE 78. INDONESIA ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
- TABLE 79. INDONESIA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
- TABLE 80. JAPAN ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 81. JAPAN ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 82. JAPAN ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
- TABLE 83. JAPAN ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
- TABLE 84. JAPAN ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
- TABLE 85. MALAYSIA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 86. MALAYSIA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 87. MALAYSIA ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
- TABLE 88. MALAYSIA ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
- TABLE 89. MALAYSIA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
- TABLE 90. PHILIPPINES ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 91. PHILIPPINES ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 92. PHILIPPINES ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
- TABLE 93. PHILIPPINES ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
- TABLE 94. PHILIPPINES ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
- TABLE 95. SINGAPORE ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 96. SINGAPORE ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 97. SINGAPORE ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
- TABLE 98. SINGAPORE ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
- TABLE 99. SINGAPORE ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
- TABLE 100. SOUTH KOREA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 101. SOUTH KOREA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 102. SOUTH KOREA ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
- TABLE 103. SOUTH KOREA ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
- TABLE 104. SOUTH KOREA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
- TABLE 105. TAIWAN ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 106. TAIWAN ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 107. TAIWAN ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
- TABLE 108. TAIWAN ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
- TABLE 109. TAIWAN ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
- TABLE 110. THAILAND ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 111. THAILAND ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 112. THAILAND ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
- TABLE 113. THAILAND ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
- TABLE 114. THAILAND ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
- TABLE 115. VIETNAM ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 116. VIETNAM ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 117. VIETNAM ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
- TABLE 118. VIETNAM ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
- TABLE 119. VIETNAM ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
- TABLE 120. EUROPE, MIDDLE EAST & AFRICA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 121. EUROPE, MIDDLE EAST & AFRICA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 122. EUROPE, MIDDLE EAST & AFRICA ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
- TABLE 123. EUROPE, MIDDLE EAST & AFRICA ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
- TABLE 124. EUROPE, MIDDLE EAST & AFRICA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
- TABLE 125. EUROPE, MIDDLE EAST & AFRICA ALLERGY DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 126. DENMARK ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 127. DENMARK ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 128. DENMARK ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
- TABLE 129. DENMARK ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
- TABLE 130. DENMARK ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
- TABLE 131. EGYPT ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 132. EGYPT ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 133. EGYPT ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
- TABLE 134. EGYPT ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
- TABLE 135. EGYPT ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
- TABLE 136. FINLAND ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 137. FINLAND ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 138. FINLAND ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
- TABLE 139. FINLAND ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
- TABLE 140. FINLAND ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
- TABLE 141. FRANCE ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 142. FRANCE ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 143. FRANCE ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
- TABLE 144. FRANCE ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
- TABLE 145. FRANCE ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
- TABLE 146. GERMANY ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 147. GERMANY ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 148. GERMANY ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
- TABLE 149. GERMANY ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
- TABLE 150. GERMANY ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
- TABLE 151. ISRAEL ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 152. ISRAEL ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 153. ISRAEL ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
- TABLE 154. ISRAEL ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
- TABLE 155. ISRAEL ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
- TABLE 156. ITALY ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 157. ITALY ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 158. ITALY ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
- TABLE 159. ITALY ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
- TABLE 160. ITALY ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
- TABLE 161. NETHERLANDS ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 162. NETHERLANDS ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 163. NETHERLANDS ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
- TABLE 164. NETHERLANDS ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
- TABLE 165. NETHERLANDS ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
- TABLE 166. NIGERIA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 167. NIGERIA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 168. NIGERIA ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
- TABLE 169. NIGERIA ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
- TABLE 170. NIGERIA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
- TABLE 171. NORWAY ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 172. NORWAY ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 173. NORWAY ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
- TABLE 174. NORWAY ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
- TABLE 175. NORWAY ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
- TABLE 176. POLAND ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 177. POLAND ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 178. POLAND ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
- TABLE 179. POLAND ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
- TABLE 180. POLAND ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
- TABLE 181. QATAR ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 182. QATAR ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 183. QATAR ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
- TABLE 184. QATAR ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
- TABLE 185. QATAR ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
- TABLE 186. RUSSIA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 187. RUSSIA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 188. RUSSIA ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
- TABLE 189. RUSSIA ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
- TABLE 190. RUSSIA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
- TABLE 191. SAUDI ARABIA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 192. SAUDI ARABIA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 193. SAUDI ARABIA ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
- TABLE 194. SAUDI ARABIA ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
- TABLE 195. SAUDI ARABIA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
- TABLE 196. SOUTH AFRICA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 197. SOUTH AFRICA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 198. SOUTH AFRICA ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
- TABLE 199. SOUTH AFRICA ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
- TABLE 200. SOUTH AFRICA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
- TABLE 201. SPAIN ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 202. SPAIN ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 203. SPAIN ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
- TABLE 204. SPAIN ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
- TABLE 205. SPAIN ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
- TABLE 206. SWEDEN ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 207. SWEDEN ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 208. SWEDEN ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
- TABLE 209. SWEDEN ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
- TABLE 210. SWEDEN ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
- TABLE 211. SWITZERLAND ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 212. SWITZERLAND ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 213. SWITZERLAND ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
- TABLE 214. SWITZERLAND ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
- TABLE 215. SWITZERLAND ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
- TABLE 216. TURKEY ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 217. TURKEY ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 218. TURKEY ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
- TABLE 219. TURKEY ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
- TABLE 220. TURKEY ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
- TABLE 221. UNITED ARAB EMIRATES ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 222. UNITED ARAB EMIRATES ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 223. UNITED ARAB EMIRATES ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
- TABLE 224. UNITED ARAB EMIRATES ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
- TABLE 225. UNITED ARAB EMIRATES ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
- TABLE 226. UNITED KINGDOM ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 227. UNITED KINGDOM ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
- TABLE 228. UNITED KINGDOM ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2030 (USD MILLION)
- TABLE 229. UNITED KINGDOM ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
- TABLE 230. UNITED KINGDOM ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
- TABLE 231. ALLERGY DRUGS MARKET, FPNV POSITIONING MATRIX, 2023
- TABLE 232. ALLERGY DRUGS MARKET SHARE, BY KEY PLAYER, 2023
- TABLE 233. ALLERGY DRUGS MARKET LICENSE & PRICING
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.